Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead ...

Pfizer was down 1.8%, along with U.S. shares of its COVID-19 vaccine partner, BioNTech, which fell 2%. Moderna dropped 1.8% ...

After a major increase in deaths from COVID-19 in December, Carver County Public Health Director Richard Scott says numbers are dropping as the new year continues. Half of the county’s death ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Acquisition to strengthen key pillar of BioNTech’s oncology strategy aimed at establishing BNT327 as a pan-tumor technology platformfor the ...

Investing.com -- Moderna (NASDAQ: NASDAQ: MRNA) stock declined 4.9% and BioNTech SE (NASDAQ: NASDAQ: BNTX) shares fell 1.5% ...

A cancer patient who has become the first person in Wales to trial a new type of vaccine says she "can't believe how lucky" ...

WASHINGTON (Reuters) - The U.S. Senate Committee on Finance was due to vote on Tuesday on advancing President Donald Trump's ...